Related Experiment Video
Updated: Jul 4, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
hERG channel blockade and additive interactions of magnolol and honokiol from Magnolia species
Wei Zhao1, Tingting Hao1, Hui Lu1
1National Key Laboratory for Development and Utilization of Forest Food Resources, Zhejiang Agriculture and Forestry University, Hangzhou 311300, China; Zhejiang Provincial Key Laboratory of Resources Protection and Innovation of Traditional Chinese Medicine, Zhejiang Agriculture and Forestry University, Hangzhou 311300, China; School of Food and Health, Zhejiang Agriculture and Forestry University, Hangzhou 311300, China.
Abstract:
The Magnolia officinalis cortex (the dried bark known as "Houpo") is widely used in traditional Chinese medicine (TCM). In this study, we discovered some potential off-target effects of M. officinalis due to the blocking effects on hERG (human Ether-a-go-go-Related Gene) channels by magnolol and honokiol, two main active chemicals of M. officialis. This research investigated the modulatory effects of two neolignans and their cooperative effects on hERG channels using manual whole-cell patch-clamp techniques. Results showed that magnolol and honokiol blocked hERG currents with IC50s of 5.2 ± 0.3 µM and 4.7 ± 0.5 µM. The blockade induced by two neolignans not only increased with increasing depolarizing strengths and durations but also significantly altered hERG activation and inactivation properties, which suggested a preferential binding to open or inactivated states. The reduced blockade by the less inactivating S631 A mutation supported their inactivation preference. We also discovered an overall additive effect of two neolignans, which might increase potential cardiotoxic risks. To our knowledge, this is the first report of the additive effects of two chemicals from one herb on hERG channels and also the first discovery of neolignans acting as hERG blockers. In conclusion, magnolol and honokiol can block hERG channels in a similar way and an additive effect exists among them. The results add to the understanding of the cardiovascular risk profile of Magnolia herbs.
Related Concept Videos
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Heart Failure Drugs: Inotropic Agents
